Epstein Secrets

f the lawsuits have been thrown out and none has included any evidence that the outcome might be reversed." Similarly, the Washington Times (11/15, Howell, 492K) says that while Trump "says a mix of software issues and mail-in ballot chicanery cost him the election," his legal battles "have largely fa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

f the lawsuits have been thrown out and none has included any evidence that the outcome might be reversed." Similarly, the Washington Times (11/15, Howell, 492K) says that while Trump "says a mix of software issues and mail-in ballot chicanery cost him the election," his legal battles "have largely fa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

f the lawsuits have been thrown out and none has included any evidence that the outcome might be reversed." Similarly, the Washington Times (11/15, Howell, 492K) says that while Trump "says a mix of software issues and mail-in ballot chicanery cost him the election," his legal battles "have largely fa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying